SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma (Q39069350)
Jump to navigation
Jump to search
scientific article published on 28 October 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma |
scientific article published on 28 October 2013 |
Statements
1 reference
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma (English)
1 reference
E Sievers
S Aretz
D Kindler
S Michels
N Friedrichs
M Renner
J Kirfel
S Steiner
S Huss
A Koch
R Penzel
O Larsson
A Kawai
S Tanaka
H Sonobe
A Waha
P Schirmacher
G Mechtersheimer
E Wardelmann
R Büttner
28 October 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference